Frequently asked questions

Lovely Meds is a telehealth service that connects adults in eligible U.S. states with licensed clinicians. Your health information is reviewed online, and if a medication is considered appropriate, a prescription is issued and fulfilled by a state-licensed U.S. pharmacy.

Depending on eligibility and clinical judgment, clinicians may prescribe treatments such as GLP-1–based therapies (e.g., semaglutide or tirzepatide), oral formulations, peptides like sermorelin, NAD-related products, MIC/B12 or Lipo-C, and other selected wellness medications. Availability can vary over time and by state.

You complete a secure health intake form with details about your medical history, medications, allergies, and goals. A licensed clinician reviews this information and may ask follow-up questions before deciding whether to prescribe a particular treatment.

No. Completing the intake does not guarantee a prescription. The clinician will only prescribe if they believe the treatment is safe and appropriate for you based on the information you provide.

Your intake is reviewed by U.S-licensed healthcare professionals who are authorized to prescribe in the state where you are located. They follow evidence-informed protocols and use their clinical judgment for each case.

A compounded medication is a customized formulation prepared by a state-licensed compounding pharmacy when a clinician determines it may be appropriate for a specific patient. Compounded medications are not FDA-approved.

Compounded medications are not reviewed or approved by the FDA and may differ from FDA-approved products in strength, form, route of administration, or inactive ingredients. FDA-approved medications have undergone formal approval processes, while compounded products are prepared under pharmacy compounding regulations.

No. Compounded formulations are prepared by independent, state-licensed U.S. compounding pharmacies. Lovely Meds provides the telehealth platform and clinical review; the pharmacy prepares and ships the medication after a valid prescription is issued.

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved products. FDA-approved injectable versions of these medications exist separately.

A clinician may consider a compounded option when they believe a different strength, format, or route of administration may be appropriate for a specific patient. This decision is always based on individual clinical judgment, not on shortages or substitution claims.

No. Compounded products do not replace or imply equivalence to branded FDA-approved medications. They are separate, customized formulations, and patients should discuss all options with a licensed healthcare professional.

No. Lovely Meds does not market compounded products as being available due to current FDA drug shortages. Messaging related to shortages has been removed to align with transparency and regulatory expectations.

GLP-1–based medications may be one part of a broader plan that can include nutrition, physical activity, and other medical care. A licensed clinician will decide if a GLP-1 therapy is appropriate for your situation. No specific results or outcomes are guaranteed.

GLP-1 medications carry important safety information, including a boxed warning related to the potential risk of thyroid C-cell tumors. They should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2). Always discuss risks with a licensed healthcare professional.

These medications are not appropriate for everyone. They are generally not suitable for people with a personal or family history of MTC or MEN-2, for certain patients with specific medical conditions, or for those with known hypersensitivity to components of the medication. A clinician will review your profile before prescribing.

Patients taking semaglutide- or tirzepatide-containing medications may experience side effects, and these differ between individuals. Gastrointestinal symptoms, such as nausea or stomach discomfort, are commonly reported. You should review the full safety information with a clinician and seek medical guidance if any symptoms feel concerning.

Injectable formulations are administered as subcutaneous injections, while oral compounded formulations are taken by mouth as troches, according to instructions from the clinician and pharmacy. Oral compounded semaglutide or tirzepatide is not FDA-approved, even though injectable forms have FDA-approved versions.

Oral compounded GLP-1 formulations are typically supplied as troches to be used as directed by the prescribing clinician and the pharmacy’s labeling. Always follow the instructions supplied with your prescription and ask questions if anything is unclear.

Some patients prefer an option that does not involve injections, but “convenience” or “effectiveness” varies by person. No claims of superiority or guaranteed outcomes are made. A clinician can help you understand the pros and cons of available options.

Depending on your profile and clinician judgment, therapies such as sermorelin, NAD-related products, MIC/B12, Lipo-C, and certain other wellness-oriented medications may be considered. All are prescribed only after a licensed clinician reviews your intake.

Many peptide or wellness-type formulations prescribed through Lovely Meds are compounded and not FDA-approved for the specific uses described. Patients should discuss the regulatory status, risks, and alternatives with their clinician before starting therapy.

No. Individual responses vary widely. Lovely Meds does not guarantee specific outcomes such as a certain amount of weight change, energy increase, or symptom improvement.

No. Lovely Meds focuses on clearly defined treatment areas and is not a replacement for primary care. You should maintain an ongoing relationship with a local healthcare provider for comprehensive medical care, routine screening, and complex conditions.

Your information is handled using secure systems, and access is limited to the clinicians and pharmacy teams involved in your care and order fulfillment. We follow applicable privacy and data-protection requirements.

Information is shared only as needed for your care, such as with the prescribing clinician and the pharmacy filling your prescription. You may choose to share information with your primary care provider as well.

Once a prescription is issued, the state-licensed pharmacy prepares your medication and sends it to the address on file using its standard fulfillment and shipping processes. Tracking information is typically provided once the order has been dispatched.

Orders are shipped in standard packaging without visible medication names. The label is designed to focus on delivery details rather than the contents of the parcel.

Charges typically appear under the name of Lovely Meds or an associated billing entity. Product names do not appear on your statement.

Lovely Meds does not bill insurance directly. Patients may check with their insurance or benefits provider to see whether out-of-network reimbursement or use of HSA/FSA funds is possible for certain expenses.

Pricing varies by medication, formulation, and duration. Current prices are shown within the platform, and you will see the total cost before you complete checkout. Costs for compounded and FDA-approved options may differ.

Once a prescription has been processed and the pharmacy has prepared your medication, it generally cannot be returned or refunded due to pharmacy regulations. For questions about specific orders, please contact support.

If your shipment seems delayed or you have not received it within the expected timeframe, you can check the tracking information and contact support. We can help coordinate with the pharmacy or shipping carrier to investigate what happened.

Lovely Meds is available in many, but not all, U.S. states. Eligibility depends on state regulations and clinician licensing. The platform will indicate whether services are available in your state before you complete your order.

No. Lovely Meds is designed for patients located within eligible U.S. states at the time of consultation and prescribing. Services are not offered for patients located outside the United States.

No. Lovely Meds is not an emergency service. If you have severe or rapidly worsening symptoms, chest pain, difficulty breathing, thoughts of self-harm, or any other emergency, call 911 or your local emergency number immediately.

Lovely Meds reviews and updates its materials to reflect current telehealth, pharmacy, and transparency requirements. This includes clearly stating when medications are compounded, when they are not FDA-approved, and how they differ from FDA-approved options.

No. We do not represent compounded medications as identical, interchangeable, or equivalent to branded, FDA-approved products. We clarify that compounded formulations are customized and not FDA-approved.

Clinical protocols and patient-facing content are reviewed periodically and may be updated when regulations, guidance, or internal standards change. The goal is to keep information accurate, balanced, and transparent.

Yes. You are encouraged to keep your primary care provider informed. You can share information from Lovely Meds with your regular doctor so they have a complete view of your treatments and medications.

For questions about the platform, orders, or general information, you can reach our support team using the contact details on the website. For medical questions about your treatment, you should contact a licensed healthcare professional involved in your care.